tetradecanoylphorbol acetate has been researched along with Giant Cell Arteritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessandro, R; Belloni, L; Boiardi, L; Bonacini, M; Cavazza, A; Ciccia, F; Cimino, L; Croci, S; Moramarco, A; Muratore, F; Parmeggiani, M; Rizzo, A; Salvarani, C; Zerbini, A | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and Giant Cell Arteritis
Article | Year |
---|---|
Increased expression of interleukin-22 in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Calcium Ionophores; Carcinogens; Case-Control Studies; CD4-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Giant Cell Arteritis; Humans; Immunohistochemistry; In Vitro Techniques; Interleukin-22; Interleukins; Ionomycin; Leukocytes, Mononuclear; Male; Real-Time Polymerase Chain Reaction; RNA, Messenger; Temporal Arteries; Tetradecanoylphorbol Acetate | 2018 |